Selected research
Industry Research
Dental Anti-inflammatory Drugs Industry Research Report 2026
Market perspective
The global Dental Anti-inflammatory Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Dental Anti-inflammatory Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Dental Anti-inflammatory Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Dental Anti-inflammatory Drugs include 3M, Yunnan Baiyao Group, Johnson & Johnson, Merck, Roche, China Resources Double Crane Pharmaceuticals, Hengrui Medicine, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Dental Anti-inflammatory Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dental Anti-inflammatory Drugs Market by Company
3M
Yunnan Baiyao Group
Johnson & Johnson
Merck
Roche
China Resources Double Crane Pharmaceuticals
Hengrui Medicine
GSK
Bayer
Sunstar
Septodont
DenMat
Colgate-Palmolive
Bausch Health
Acteon
Dental Anti-inflammatory Drugs Segment by Type
Non-steroidal Anti-inflammatory Drugs
Antibiotics
Steroidal Anti-inflammatory Drugs
Others
Dental Anti-inflammatory Drugs Segment by Application
Clinics
Hospitals
Pharmacies
Online Sales
Others
Dental Anti-inflammatory Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dental Anti-inflammatory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dental Anti-inflammatory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dental Anti-inflammatory Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dental Anti-inflammatory Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dental Anti-inflammatory Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dental Anti-inflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Non-steroidal Anti-inflammatory Drugs
- Antibiotics
- Steroidal Anti-inflammatory Drugs
- Others
Applications
- Clinics
- Hospitals
- Pharmacies
- Online Sales
- Others
Companies covered
- 3M
- Yunnan Baiyao Group
- Johnson & Johnson
- Merck
- Roche
- China Resources Double Crane Pharmaceuticals
- Hengrui Medicine
- GSK
- Bayer
- Sunstar
- Septodont
- DenMat
- Colgate-Palmolive
- Bausch Health
- Acteon
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dental Anti-inflammatory Drugs Market Size (2021-2032)
- 2.2.2 Global Dental Anti-inflammatory Drugs Sales (2021-2032)
- 2.2.3 Global Dental Anti-inflammatory Drugs Market Average Price (2021-2032)
- 2.3 Dental Anti-inflammatory Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Non-steroidal Anti-inflammatory Drugs
- 2.3.3 Antibiotics
- 2.3.4 Steroidal Anti-inflammatory Drugs
- 2.3.5 Others
- 2.4 Dental Anti-inflammatory Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospitals
- 2.4.4 Pharmacies
- 2.4.5 Online Sales
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dental Anti-inflammatory Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dental Anti-inflammatory Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Dental Anti-inflammatory Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Dental Anti-inflammatory Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Dental Anti-inflammatory Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dental Anti-inflammatory Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dental Anti-inflammatory Drugs, Product Type & Application
- 3.8 Global Manufacturers of Dental Anti-inflammatory Drugs, Established Date
- 3.9 Global Dental Anti-inflammatory Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 3M
- 4.1.1 3M Company Information
- 4.1.2 3M Business Overview
- 4.1.3 3M Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 3M Dental Anti-inflammatory Drugs Product Portfolio
- 4.1.5 3M Recent Developments
- 4.2 Yunnan Baiyao Group
- 4.2.1 Yunnan Baiyao Group Company Information
- 4.2.2 Yunnan Baiyao Group Business Overview
- 4.2.3 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Product Portfolio
- 4.2.5 Yunnan Baiyao Group Recent Developments
- 4.3 Johnson & Johnson
- 4.3.1 Johnson & Johnson Company Information
- 4.3.2 Johnson & Johnson Business Overview
- 4.3.3 Johnson & Johnson Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Johnson & Johnson Dental Anti-inflammatory Drugs Product Portfolio
- 4.3.5 Johnson & Johnson Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Dental Anti-inflammatory Drugs Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Roche
- 4.5.1 Roche Company Information
- 4.5.2 Roche Business Overview
- 4.5.3 Roche Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Roche Dental Anti-inflammatory Drugs Product Portfolio
- 4.5.5 Roche Recent Developments
- 4.6 China Resources Double Crane Pharmaceuticals
- 4.6.1 China Resources Double Crane Pharmaceuticals Company Information
- 4.6.2 China Resources Double Crane Pharmaceuticals Business Overview
- 4.6.3 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolio
- 4.6.5 China Resources Double Crane Pharmaceuticals Recent Developments
- 4.7 Hengrui Medicine
- 4.7.1 Hengrui Medicine Company Information
- 4.7.2 Hengrui Medicine Business Overview
- 4.7.3 Hengrui Medicine Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hengrui Medicine Dental Anti-inflammatory Drugs Product Portfolio
- 4.7.5 Hengrui Medicine Recent Developments
- 4.8 GSK
- 4.8.1 GSK Company Information
- 4.8.2 GSK Business Overview
- 4.8.3 GSK Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 GSK Dental Anti-inflammatory Drugs Product Portfolio
- 4.8.5 GSK Recent Developments
- 4.9 Bayer
- 4.9.1 Bayer Company Information
- 4.9.2 Bayer Business Overview
- 4.9.3 Bayer Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bayer Dental Anti-inflammatory Drugs Product Portfolio
- 4.9.5 Bayer Recent Developments
- 4.10 Sunstar
- 4.10.1 Sunstar Company Information
- 4.10.2 Sunstar Business Overview
- 4.10.3 Sunstar Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sunstar Dental Anti-inflammatory Drugs Product Portfolio
- 4.10.5 Sunstar Recent Developments
- 4.11 Septodont
- 4.11.1 Septodont Company Information
- 4.11.2 Septodont Business Overview
- 4.11.3 Septodont Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Septodont Dental Anti-inflammatory Drugs Product Portfolio
- 4.11.5 Septodont Recent Developments
- 4.12 DenMat
- 4.12.1 DenMat Company Information
- 4.12.2 DenMat Business Overview
- 4.12.3 DenMat Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 DenMat Dental Anti-inflammatory Drugs Product Portfolio
- 4.12.5 DenMat Recent Developments
- 4.13 Colgate-Palmolive
- 4.13.1 Colgate-Palmolive Company Information
- 4.13.2 Colgate-Palmolive Business Overview
- 4.13.3 Colgate-Palmolive Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Colgate-Palmolive Dental Anti-inflammatory Drugs Product Portfolio
- 4.13.5 Colgate-Palmolive Recent Developments
- 4.14 Bausch Health
- 4.14.1 Bausch Health Company Information
- 4.14.2 Bausch Health Business Overview
- 4.14.3 Bausch Health Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bausch Health Dental Anti-inflammatory Drugs Product Portfolio
- 4.14.5 Bausch Health Recent Developments
- 4.15 Acteon
- 4.15.1 Acteon Company Information
- 4.15.2 Acteon Business Overview
- 4.15.3 Acteon Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Acteon Dental Anti-inflammatory Drugs Product Portfolio
- 4.15.5 Acteon Recent Developments
5 Global Dental Anti-inflammatory Drugs Market Scenario by Region
- 5.1 Global Dental Anti-inflammatory Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dental Anti-inflammatory Drugs Sales by Region: 2021-2032
- 5.2.1 Global Dental Anti-inflammatory Drugs Sales by Region: 2021-2026
- 5.2.2 Global Dental Anti-inflammatory Drugs Sales by Region: 2027-2032
- 5.3 Global Dental Anti-inflammatory Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Dental Anti-inflammatory Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Dental Anti-inflammatory Drugs Revenue by Region: 2027-2032
- 5.4 North America Dental Anti-inflammatory Drugs Market Facts & Figures by Country
- 5.4.1 North America Dental Anti-inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
- 5.4.3 North America Dental Anti-inflammatory Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Dental Anti-inflammatory Drugs Market Facts & Figures by Country
- 5.5.1 Europe Dental Anti-inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Dental Anti-inflammatory Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Dental Anti-inflammatory Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dental Anti-inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dental Anti-inflammatory Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dental Anti-inflammatory Drugs Market Facts & Figures by Country
- 5.7.1 South America Dental Anti-inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
- 5.7.3 South America Dental Anti-inflammatory Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Dental Anti-inflammatory Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dental Anti-inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dental Anti-inflammatory Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dental Anti-inflammatory Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Dental Anti-inflammatory Drugs Sales by Type (2021-2032)
- 6.1.1 Global Dental Anti-inflammatory Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Dental Anti-inflammatory Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Dental Anti-inflammatory Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Dental Anti-inflammatory Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dental Anti-inflammatory Drugs Sales by Application (2021-2032)
- 7.1.1 Global Dental Anti-inflammatory Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Dental Anti-inflammatory Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Dental Anti-inflammatory Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Dental Anti-inflammatory Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dental Anti-inflammatory Drugs Value Chain Analysis
- 8.1.1 Dental Anti-inflammatory Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dental Anti-inflammatory Drugs Production Mode & Process
- 8.2 Dental Anti-inflammatory Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dental Anti-inflammatory Drugs Distributors
- 8.2.3 Dental Anti-inflammatory Drugs Customers
9 Global Dental Anti-inflammatory Drugs Analyzing Market Dynamics
- 9.1 Dental Anti-inflammatory Drugs Industry Trends
- 9.2 Dental Anti-inflammatory Drugs Industry Drivers
- 9.3 Dental Anti-inflammatory Drugs Industry Opportunities and Challenges
- 9.4 Dental Anti-inflammatory Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst